Latest in Idrx 1.15bn
Sort by
1 items
-
GSK to buy US cancer drug firm IDRx for up to $1.15bn
Massachusetts-based company is working on new treatments for gastrointestinal cancers. Business live – latest updates GSK has struck a deal worth up to $1.15bn (£950m) to acquire a ...The Guardian - 1d